Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

25,188 signal articles · 250 in last 24h · 120,076 total before filter · latest 17m ago
250last 24h
1441last 7d
242● bullish (7d)
155● bearish (7d)
205publishers
AllMacro258Earnings545M&A100Regulatory19Product11Analyst22
✕ clear all filterssentiment: bullishSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Amazon (AMZN) Wins First US Approval For Commercial Driverless Robotaxis
Simply Wall St.19d agobullish
Amazon (AMZN) Wins First US Approval For Commercial Driverless Robotaxis

Amazon subsidiary Zoox received the first U.S. federal approval to deploy a commercial, driverless robotaxi service without traditional human controls. The approval from NHTSA allows Zoox to begin commercial operations in Las Vegas, subject to state level requirements. This is the first time a fully autonomous vehicle without a steering wheel or pedals has been cleared for commercial ride hailing in the U.S. For Amazon.com, Inc. (NasdaqGS:AMZN), Zoox represents a move into autonomous ride...

MPWR Q2 Deep Dive: Data Center and Communications Growth Drive Outperformance, Automotive Expands
StockStory19d agobullish
MPWR Q2 Deep Dive: Data Center and Communications Growth Drive Outperformance, Automotive Expands

Power management chips maker Monolithic Power Systems (NASDAQ:MPWR) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 47.6% year on year to $980.6 million. On top of that, next quarter’s revenue guidance ($1.15 billion at the midpoint) was surprisingly good and 16.5% above what analysts were expecting. Its non-GAAP profit of $6.50 per share was 10.5% above analysts’ consensus estimates.

AbbVie (ABBV) Wins EU Approval For RINVOQ In Vitiligo And Alopecia
Simply Wall St.19d agobullish
AbbVie (ABBV) Wins EU Approval For RINVOQ In Vitiligo And Alopecia

AbbVie (NYSE:ABBV) received European Commission approval for RINVOQ (upadacitinib) as the first systemic treatment in the EU for non segmental vitiligo. The decision also covers RINVOQ as a systemic option for severe alopecia areata in adults and adolescents. These approvals expand RINVOQ’s labeled uses in Europe and add new indications in dermatology and immunology. For investors following AbbVie, this move adds fresh detail to the story around its immunology franchise. The company...

Should Stronger Q2 Earnings and Upbeat Signals at Vicor (VICR) Require Action From Investors?
Simply Wall St.19d agobullish
Should Stronger Q2 Earnings and Upbeat Signals at Vicor (VICR) Require Action From Investors?

Vicor Corporation’s recently reported second-quarter 2026 results showed revenue of US$143.35 million and net income of US$49.77 million, both higher than the same period a year earlier, with basic earnings per share rising to US$1.08 from US$0.92. These stronger earnings, together with higher Wall Street earnings estimates and technical signals pointing to renewed buyer interest, are drawing attention to Vicor’s near-term power in its core markets. With revenue and earnings improving year...

Market Talk: Apple sinks, Amazon soars in split verdict on AI winners
Reuters Videos19d agobullishVIDEO
Market Talk: Apple sinks, Amazon soars in split verdict on AI winners

<body><p>STORY: :: Recorded on July 31</p><p>:: Lisa Bernhard, Reuters</p><p>:: Dean Smith, Portfolio Manager, FolioBeyond</p><p>Shares of Apple tumbled as much as 10% on Friday after a disappointing forecast showed that the iPhone maker was struggling to secure enough components as the AI-driven data center boom strains global supply chains.</p><p>The drop, if sustained, would erase nearly $500 billion from Apple's market capitalization and return the crown of the world's most valuable company to AI chip giant Nvidia, days after reclaiming it.</p><p>Meanwhile, shares of Amazon soared as much as 15% after the tech giant's solid cloud sales growth reinforced investor confidence in its massive AI bets.</p><p>"There's two really different trends going on," said Smith. "One is the hardware constraint, the [other is] cloud compute capacity, and those are going to continue to drive what we see in the AI investment thesis."</p><p>Next week, the focus will remain on AI when SpaceX delivers its first quarterly earnings results since going public.</p><p>"There's no mystery about how many rockets they're firing off, we can see them," said Dean with a laugh. "So what I'm looking for in SpaceX is to see what is their plan for the AI side of the business."</p></body>

3 Market-Beating Stocks to Target This Week
StockStory19d agobullish
3 Market-Beating Stocks to Target This Week

Companies that consistently increase their sales, margins, or returns on capital are usually rewarded with the best returns, and those that can do all three for years on end are almost always the legendary stocks that return 100 times your money.

Ambarella stock surges on reported NXP takeover talks
InvestorsHub19d agobullish
Ambarella stock surges on reported NXP takeover talks

Key takeawaysAmbarella shares jumped nearly 20 per cent after reports that NXP Semiconductors is considering an acquisition worth more than US$3 billion. The rally lifted Ambarella’s market capitalization to almost US$3.